3-Methyl-N-(3-((3-(trifluoromethyl)phenyl)carbamoyl)phenyl)isoxazole-5-carboxamide
(S)-N-(3-Bromophenyl)-N'-cyano-2-methyl-4-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboximidamide
N-Benzyl-4-(N-benzylsulfamoyl)benzamide
N-(5-(1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)thiazol-2-yl)cyclopropanecarboxamide
N-(5-(1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyramide
N-Benzyl-N-butyl-4-(N-phenylsulfamoyl)benzamide
Methyl 2-(1-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl)-1H-benzo[d]imidazole-6-carboxylate
N-(2-(N-Benzyl-4-(N-phenylsulfamoyl)benzamido)ethyl)-2-isobutyramidothiazole-5-carboxamide
DD-03-156
Bcl-2-IN-16
SM1-71
1-(2-Hydroxyethyl)-3-(4-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)-1-phenylurea
LIMK1 inhibitor BMS-4
CRT-0105446
(4AR,5R,8R,8aR)-5,8-dihydroxy-3,5,8a-trimethyl-5,6,7,8,8a,9-hexahydronaphtho[2,3-b]furan-4(4aH)-one
8β,9α-Dihydroxylindan-4(5),7(11)-dien-8alpha,12-olide
4-((5-(3-(2-Chloro-4-methylphenyl)pyridin-4-yl)thiazol-2-yl)amino)phenol
